SCHEMBL29742014

SCHEMBL29742014

CCCCOC(=O)N1CCC(c2ccc(N)nc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPC6 Q9Y210 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
MMP13 P45452 2/20 0.42
GPR119 Q8TDV5 2/20 0.41
HRH2 P25021 1/20 0.41
HRH1 P35367 1/20 0.41
PDE4B Q07343 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
HPGD P15428 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40
NPC1 O15118 1/20 0.40
ALDH1A1 P00352 1/20 0.40
RAB9A P51151 1/20 0.40
DDB1 Q16531 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30376364 0.87 LMNA (0.49) SMN1; SMN2LMNAPOLBMMP13HRH2
SCHEMBL30643624 0.81 GPR119 (0.43) TRPC6SMN1; SMN2LMNAPOLBMMP13
SCHEMBL2025839 0.80 PDE4B (0.53) SMN1; SMN2LMNAPOLBPDE4BHPGD
SCHEMBL30643578 0.80 FAAH (0.41) SMN1; SMN2LMNAPOLBMMP13GPR119
SCHEMBL8922008 0.79 CHRM4 (0.59) SMN1; SMN2LMNAPOLBNPC1ALDH1A1
SCHEMBL27926722 0.79 TRPC6 (0.51) TRPC6
SCHEMBL21273836 0.79 TRPC6 (0.66) TRPC6
SCHEMBL27694790 0.79 MAPT (0.49) TRPC6SMN1; SMN2LMNAPOLBHRH2
SCHEMBL29497122 0.79 DDB1 (0.60) TRPC6GPR119DDB1CRBN
SCHEMBL611718 0.79 DDB1 (0.60) TRPC6GPR119DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4050012-A1 PYRIDONE BORONATES FOR THE PREPARATION OF INHIBITORS OF BTK ACTIVITY F. Hoffmann-La Roche AG (CH) 2022-08-31 EP disclosed
EP-4019508-A1 HETEROARYL PYRIDONE AND AZA-PYRIDONE COMPOUNDS AS INHIBITORS OF BTK ACTIVITY F. Hoffmann-La Roche AG (CH) 2022-06-29 EP disclosed